department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

trametinib · pharmadog

pharmadog
drugs
trametinib

drug

patient view →

trametinib

Preclinicalupdated 2mo ago

by Genuv Inc

Preclinical

community read0 votes

indications

indications

Alzheimer's Disease

all catalysts(0)

nothing on the calendar yet

News(0)

no news has mentioned this drug yet

generic

trametinib

indication

Alzheimer's Disease

phase

preclinical

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Data sources

ClinicalTrials.gov

last refreshed 53m ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

🐶 often sniffed alongside

top 6

tagApproval86 co-mentions · 43 sources
drugMEKINIST76 co-mentions · 43 sources
drugtrametinib dimethyl sulfoxide76 co-mentions · 43 sources
drugSpexotras76 co-mentions · 43 sources
tagSmall Molecule43 co-mentions · 43 sources
drugRimso33 co-mentions · 33 sources

Trials studying trametinib

phase2Pan Tumor Rollover Studyrecruitingn=1,500
phase4Dabrafenib and/or Trametinib Rollover Studyrecruitingn=100
phase2Rollover Study for Participants Who Have Been Treated With and Are Continuing to Benefit From Opnurasib as a Single Agent or in Combination With Other Study Treatmentsrecruitingn=40
phase2TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancerrecruitingn=4,200
phase4Pediatric Long-Term Follow-up and Rollover Studyrecruitingn=165
phase224VA021; VATCH Trametinib for Ras/MAPK Pathway VAsactive not recruitingn=45
phase3Dabrafenib With Trametinib in the Adjuvant Treatment of High-risk BRAF V600 Mutation-positive Melanoma (COMBI-AD).completedn=870
phase2Abbreviated MAPK Targeted Therapy Plus Pembrolizumab in Melanomaactive not recruitingn=16

more trials →